<p>(A–B) EZH2 knockdown is efficient and specific. MDA MB 435, 435-Brain 1, and 435-Lung 2 cells were transfected with either EZH2 specific siRNA or with control siRNA. 10% of lysates were subjected to immunoblot (IB) for EZH2 and tubulin. Results reported are representative data from three independent experiments. The remaining lysates were subjected to EZH2 mRNA isolation and quantitation by Q-PCR. Q-PCR was performed in triplicate and results shown represent the mean ± SD of three independent experiments. (C) Levels of trimethylated H3K27 in breast cancer cells. ChIP assays were carried out in MDA MB 435 variants transfected with either EZH2 siRNA or control siRNA and stimulated as indicated with IFN-γ. Lysates were IP with control antib...
Although global H3K27me3 reprogramming is a hallmark of cancer, no effective therapeutic strategy fo...
<p>(<b>A</b>) ChIP-Ezh2-quantitative PCR (qPCR) analysis. The graph shows quantitative PCR on DNA pu...
Background Many cancers show aberrant silencing of gene expression and overexpression of histone met...
Control of gene expression is exerted at a number of different levels, one of which is the accessibi...
<p>(A–B) MDA MB 435 variants were transfected with either EZH2 specific siRNA or with control siRNA ...
<p>(A) EZH2 mRNA expression. MDA MB 435, 435-Brain 1, 435-Lung 2, and HeLa cells were stimulated as ...
Polycomb repressive complex 2 (PRC2) and its core member enhancer of zeste homolog 2 (EZH2) mediate ...
<p><b>(A)</b> Western blot showing reduced global H3K27me3 levels in KARPAS-422 cells treated with 1...
EZH2, die katalytische Untereinheit des Polycomb repressive complex 2 (PRC2), ist für die Mono-, Di-...
<p>(<b>A, E</b>) To confirm knockdown of EZH2, RNA was extracted from the transfected lines and qPCR...
International audienceMerkel cell carcinoma (MCC) is an aggressive skin cancer for which Merkel cell...
<p><b>A </b><i>EZH2</i> transcript expression was decreased 24 h after si<i>EZH2</i> treatment (left...
EZH2 or EZH1 is the catalytic subunit of the polycomb repressive complex 2 that catalyzes methylatio...
EZH2/PRC2 catalyzes transcriptionally repressive methylation at lysine 27 of histone H3 and has been...
Somatic mutations in non-Hodgkin's lymphoma frequently activate EZH2, a protein methyltransferase re...
Although global H3K27me3 reprogramming is a hallmark of cancer, no effective therapeutic strategy fo...
<p>(<b>A</b>) ChIP-Ezh2-quantitative PCR (qPCR) analysis. The graph shows quantitative PCR on DNA pu...
Background Many cancers show aberrant silencing of gene expression and overexpression of histone met...
Control of gene expression is exerted at a number of different levels, one of which is the accessibi...
<p>(A–B) MDA MB 435 variants were transfected with either EZH2 specific siRNA or with control siRNA ...
<p>(A) EZH2 mRNA expression. MDA MB 435, 435-Brain 1, 435-Lung 2, and HeLa cells were stimulated as ...
Polycomb repressive complex 2 (PRC2) and its core member enhancer of zeste homolog 2 (EZH2) mediate ...
<p><b>(A)</b> Western blot showing reduced global H3K27me3 levels in KARPAS-422 cells treated with 1...
EZH2, die katalytische Untereinheit des Polycomb repressive complex 2 (PRC2), ist für die Mono-, Di-...
<p>(<b>A, E</b>) To confirm knockdown of EZH2, RNA was extracted from the transfected lines and qPCR...
International audienceMerkel cell carcinoma (MCC) is an aggressive skin cancer for which Merkel cell...
<p><b>A </b><i>EZH2</i> transcript expression was decreased 24 h after si<i>EZH2</i> treatment (left...
EZH2 or EZH1 is the catalytic subunit of the polycomb repressive complex 2 that catalyzes methylatio...
EZH2/PRC2 catalyzes transcriptionally repressive methylation at lysine 27 of histone H3 and has been...
Somatic mutations in non-Hodgkin's lymphoma frequently activate EZH2, a protein methyltransferase re...
Although global H3K27me3 reprogramming is a hallmark of cancer, no effective therapeutic strategy fo...
<p>(<b>A</b>) ChIP-Ezh2-quantitative PCR (qPCR) analysis. The graph shows quantitative PCR on DNA pu...
Background Many cancers show aberrant silencing of gene expression and overexpression of histone met...